{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:28:06Z","timestamp":1791998886459,"version":"4.4.0"},"reference-count":46,"publisher":"Japan Epidemiological Association","issue":"12","funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15dk0207003h0003|15dk0207009h0002|15ek0210001h0003|15ek0210004h0002"],"award-info":[{"award-number":["15dk0207003h0003|15dk0207009h0002|15ek0210001h0003|15ek0210004h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"publisher","award":["ScientificResearch_A_25253048|ScientificResearch_C_15K09267|ScientificResearch_C_15K09835|ScientificResearch_C_25460758|ScientificResearch_C_26350895|ScientificResearch_C_26460748|ScientiricResearch_C_15K08738"],"award-info":[{"award-number":["ScientificResearch_A_25253048|ScientificResearch_C_15K09267|ScientificResearch_C_15K09835|ScientificResearch_C_25460758|ScientificResearch_C_26350895|ScientificResearch_C_26460748|ScientiricResearch_C_15K08738"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H25-Junkankitou[Seishuu]-Sitei-022|H26-Junkankitou[Seisaku]-Ippan-001|H27-Shokuhin-Sitei-017"],"award-info":[{"award-number":["H25-Junkankitou[Seishuu]-Sitei-022|H26-Junkankitou[Seisaku]-Ippan-001|H27-Shokuhin-Sitei-017"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Epidemiology"],"published-print":{"date-parts":[[2016]]},"DOI":"10.2188\/jea.je20150258","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T18:35:31Z","timestamp":1464978931000},"page":"629-636","source":"Crossref","is-referenced-by-count":63,"title":["Combination of &lt;i&gt;Helicobacter pylori&lt;\/i&gt; Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study"],"prefix":"10.2188","volume":"26","author":[{"given":"Fumie","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Shikata","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yonemoto","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Kurume University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Esaki","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kiyohara","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"991","reference":[{"key":"1","unstructured":"1. International Agency for Research on Cancer. IRAC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 61. Schistosomes, Liver Flukes and <i>Helicobacter pylori<\/i>. Lyon: IARC press; 1994."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yamagata H, Kiyohara Y, Aoyagi K, Kato I, Iwamoto H, Nakayama K, et&nbsp;al. Impact of <i>Helicobacter pylori<\/i> infection on gastric cancer incidence in a general Japanese population: the Hisayama Study. Arch Intern Med. 2000;160:1962&ndash;8.","DOI":"10.1001\/archinte.160.13.1962"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et&nbsp;al. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med. 2001;345:784&ndash;9.","DOI":"10.1056\/NEJMoa001999"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et&nbsp;al. Effect of eradication of <i>Helicobacter pylori<\/i> on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392&ndash;7.","DOI":"10.1016\/S0140-6736(08)61159-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Walker IR, Strickland RG, Ungar B, Mackay IR. Simple atrophic gastritis and gastric carcinoma. Gut. 1971;12:906&ndash;11.","DOI":"10.1136\/gut.12.11.906"},{"key":"6","unstructured":"6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process&mdash;First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735&ndash;40."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tatsuta M, Iishi H, Nakaizumi A, Okuda S, Taniguchi H, Hiyama T, et&nbsp;al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer. 1993;53:70&ndash;4.","DOI":"10.1002\/ijc.2910530114"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Inoue M, Tajima K, Matsuura A, Suzuki T, Nakamura T, Ohashi K, et&nbsp;al. Severity of chronic atrophic gastritis and subsequent gastric cancer occurrence: a 10-year prospective cohort study in Japan. Cancer Lett. 2000;161:105&ndash;12.","DOI":"10.1016\/S0304-3835(00)00603-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Evans DJ Jr, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of <i>Campylobacter pylori<\/i> infection. Gastroenterology. 1989;96:1004&ndash;8.","DOI":"10.1016\/0016-5085(89)91616-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol. 2003;98:735&ndash;9.","DOI":"10.1111\/j.1572-0241.2003.07410.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006;9:245&ndash;53.","DOI":"10.1007\/s10120-006-0397-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between <i>Helicobacter pylori<\/i> seropositivity and gastric cancer. Gastroenterology. 1998;114:1169&ndash;79.","DOI":"10.1016\/S0016-5085(98)70422-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Helicobacter and Cancer Collaborative Group. Gastric cancer and <i>Helicobacter pylori<\/i>: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347&ndash;53.","DOI":"10.1136\/gut.49.3.347"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, et&nbsp;al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama Study. Am J Epidemiol. 2006;163:629&ndash;37.","DOI":"10.1093\/aje\/kwj088"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shikata K, Ninomiya T, Yonemoto K, Ikeda F, Hata J, Doi Y, et&nbsp;al. Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study. Scand J Gastroenterol. 2012;47:669&ndash;75.","DOI":"10.3109\/00365521.2012.658855"},{"key":"16","unstructured":"16. Plummer M, Vivas J, Fauch&egrave;re JL, Del Giudice G, Pe&ntilde;a AS, Ponzetto A, et&nbsp;al. <i>Helicobacter pylori<\/i> and stomach cancer: a case-control study in Venezuela. Cancer Epidemiol Biomarkers Prev. 2000;9:961&ndash;5."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Miki K. Gastric cancer screening by combined assay for serum anti-<i>Helicobacter pylori<\/i> IgG antibody and serum pepsinogen levels&mdash;&ldquo;ABC method&rdquo;. Proc Jpn Acad, Ser B, Phys Biol Sci. 2011;87:405&ndash;14.","DOI":"10.2183\/pjab.87.405"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et&nbsp;al. Progression of chronic atrophic gastritis associated with <i>Helicobacter pylori<\/i> infection increases risk of gastric cancer. Int J Cancer. 2004;109:138&ndash;43.","DOI":"10.1002\/ijc.11680"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et&nbsp;al. Predicting the development of gastric cancer from combining <i>Helicobacter pylori<\/i> antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764&ndash;8.","DOI":"10.1136\/gut.2004.055400"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mizuno S, Miki I, Ishida T, Yoshida M, Onoyama M, Azuma T, et&nbsp;al. Prescreening of a high-risk group for gastric cancer by serologically determined <i>Helicobacter pylori<\/i> infection and atrophic gastritis. Dig Dis Sci. 2010;55:3132&ndash;7.","DOI":"10.1007\/s10620-010-1154-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J, et&nbsp;al. Low serum pepsinogen I and pepsinogen I\/II ratio and <i>Helicobacter pylori<\/i> infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer. 2012;130:1614&ndash;9.","DOI":"10.1002\/ijc.26172"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, et&nbsp;al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study. Diabetologia. 1993;36:1198&ndash;203.","DOI":"10.1007\/BF00401066"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101&ndash;12.","DOI":"10.1007\/s10120-011-0041-5"},{"key":"24","unstructured":"24. Shirota T, Yoshizumi E. Accuracy of nutritional survey using the simple method. Nihon Koshu Eisei Zasshi. 1990;37:100&ndash;8 (in Japanese)."},{"key":"25","unstructured":"25. Resources Council of the Science and Technology Agency. Standard tables of food composition in Japan, 4th ed. Tokyo, Japan: Ministry of Finance Printing Bureau; 1982 (in Japanese)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17&ndash;27.","DOI":"10.1093\/oxfordjournals.aje.a114366"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20:633&ndash;49.","DOI":"10.1016\/j.bpg.2006.04.008"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, et&nbsp;al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama Study. Int J Cancer. 2006;119:196&ndash;201.","DOI":"10.1002\/ijc.21822"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, Kubo M, et&nbsp;al. Population-based prospective study of the combined influence of cigarette smoking and <i>Helicobacter pylori<\/i> infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol. 2008;168:1409&ndash;15.","DOI":"10.1093\/aje\/kwn276"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Asano K, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, et&nbsp;al. Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama Study. Int J Cancer. 2008;122:909&ndash;14.","DOI":"10.1002\/ijc.23191"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ikeda F, Doi Y, Yonemoto K, Ninomiya T, Kubo M, Shikata K, et&nbsp;al. Hyperglycemia increases risk of gastric cancer posed by <i>Helicobacter pylori<\/i> infection: a population-based cohort study. Gastroenterology. 2009;136:1234&ndash;41.","DOI":"10.1053\/j.gastro.2008.12.045"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Miyazaki M, Doi Y, Ikeda F, Ninomiya T, Hata J, Uchida K, et&nbsp;al. Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study. Gastric Cancer. 2012;15:162&ndash;9.","DOI":"10.1007\/s10120-011-0092-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989.","DOI":"10.2307\/2531779"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Pencina MJ, D&rsquo;Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109&ndash;23.","DOI":"10.1002\/sim.1802"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837&ndash;45.","DOI":"10.2307\/2531595"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Pencina MJ, D&rsquo;Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11&ndash;21.","DOI":"10.1002\/sim.4085"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, et&nbsp;al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408&ndash;16.","DOI":"10.1161\/CIRCULATIONAHA.109.192278"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et&nbsp;al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128&ndash;38.","DOI":"10.1097\/EDE.0b013e3181c30fb2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Terasawa T, Nishida H, Kato K, Miyashiro I, Yoshikawa T, Takaku R, et&nbsp;al. Prediction of gastric cancer development by serum pepsinogen test and <i>Helicobacter pylori<\/i> seropositivity in Eastern Asians: a systematic review and meta-analysis. PLoS One. 2014;9:e109783.","DOI":"10.1371\/journal.pone.0109783"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C, et&nbsp;al. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and <i>Helicobacter pylori<\/i> antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer. 2012;131:2632&ndash;42.","DOI":"10.1002\/ijc.27514"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of <i>Helicobacter pylori<\/i>-negative gastric cancer among Japanese. Helicobacter. 2011;16:415&ndash;9.","DOI":"10.1111\/j.1523-5378.2011.00889.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Miwa H, Kikuchi S, Ohtaka K, Kobayashi O, Ogihara A, Hojo M, et&nbsp;al. Insufficient diagnostic accuracy of imported serological kits for <i>Helicobacter pylori<\/i> infection in Japanese population. Diagn Microbiol Infect Dis. 2000;36:95&ndash;9.","DOI":"10.1016\/S0732-8893(99)00143-1"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hattori Y, Tashiro H, Kawamoto T, Kodama Y. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens. Jpn J Cancer Res. 1995;86:1210&ndash;5.","DOI":"10.1111\/j.1349-7006.1995.tb03317.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Inoue K, Fujisawa T, Haruma K. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum <i>Helicobacter pylori<\/i> antibodies. Int J Biol Markers. 2010;25:207&ndash;12.","DOI":"10.5301\/JBM.2010.6087"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, et&nbsp;al. Guidelines for the management of <i>Helicobacter<\/i> pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1&ndash;20.","DOI":"10.1111\/j.1523-5378.2009.00738.x"},{"key":"46","unstructured":"46. Yoshizawa K, Oizumi H, Sasaki Y, Abe Y, Kanno N, Sakuta K, et&nbsp;al. Characteristics of group A patients according to the ABC classification for gastric cancer risk screening. Nihon Shokakibyo Gakkai Zasshi. 2015;112:1492&ndash;502 (in Japanese)."}],"container-title":["Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/26\/12\/26_JE20150258\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T03:42:09Z","timestamp":1568000529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/26\/12\/26_JE20150258\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2188\/jea.je20150258","relation":{},"ISSN":["0917-5040","1349-9092"],"issn-type":[{"value":"0917-5040","type":"print"},{"value":"1349-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}